These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

542 related items for PubMed ID: 6604604

  • 1. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus.
    Daha MR, Hazevoet HM, Vanes LA.
    Clin Exp Immunol; 1983 Sep; 53(3):541-6. PubMed ID: 6604604
    [Abstract] [Full Text] [Related]

  • 2. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus.
    Daha MR, Hazevoet HM, Hermans J, van Es LA, Cats A.
    Clin Exp Immunol; 1983 Oct; 54(1):248-52. PubMed ID: 6604610
    [Abstract] [Full Text] [Related]

  • 3. Heterogeneity, polypeptide chain composition and antigenic reactivity of autoantibodies (F-42) that are directed against the classical pathway C3 convertase of complement and isolated from sera of patients with systemic lupus erythematosus.
    Daha MR, Hazevoet HM, van Es LA.
    Clin Exp Immunol; 1984 Jun; 56(3):614-20. PubMed ID: 6430610
    [Abstract] [Full Text] [Related]

  • 4. Relative resistance of the F-42-stabilized classical pathway C3 convertase to inactivation by C4-binding protein.
    Daha MR, van Es LA.
    J Immunol; 1980 Nov; 125(5):2051-4. PubMed ID: 6903579
    [Abstract] [Full Text] [Related]

  • 5. Prevention of immune precipitation by purified classical pathway complement components.
    Naama JK, Hamilton AO, Yeung-Laiwah AC, Whaley K.
    Clin Exp Immunol; 1984 Nov; 58(2):486-92. PubMed ID: 6333948
    [Abstract] [Full Text] [Related]

  • 6. Complement activating cryoglobulins in the nephritis of systemic lupus erythematosus.
    Adu D, Williams DG.
    Clin Exp Immunol; 1984 Mar; 55(3):495-501. PubMed ID: 6705265
    [Abstract] [Full Text] [Related]

  • 7. The influence of classical pathway components during alternative pathway--modulated immune complex aggregation: the role of C1 INH.
    Gronski P, Bodenbender L, Kanzy EJ, Seiler FR.
    Behring Inst Mitt; 1984 Nov; (76):29-41. PubMed ID: 6335396
    [Abstract] [Full Text] [Related]

  • 8. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA, Goldman RC, Hammer CH, Leive L, Frank MM.
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [Abstract] [Full Text] [Related]

  • 9. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
    Ziccardi RJ.
    J Immunol; 1986 May 01; 136(9):3378-83. PubMed ID: 3485688
    [Abstract] [Full Text] [Related]

  • 10. Relationship between the component and regulatory proteins of the classical pathway C3 convertase.
    Welch TR, Forristal J, Beischel L.
    J Lab Clin Med; 1986 Jun 01; 107(6):529-33. PubMed ID: 3635565
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of immune precipitation by complement.
    Hong K, Takata Y, Sayama K, Kozono H, Takeda J, Nakano Y, Kinoshita T, Inoue K.
    J Immunol; 1984 Sep 01; 133(3):1464-70. PubMed ID: 6747294
    [Abstract] [Full Text] [Related]

  • 12. C1- inactivator: its efficiency as a regulator of classical complement pathway activation by soluble IgG aggregates.
    Doekes G, van Es LA, Daha MR.
    Immunology; 1983 Jun 01; 49(2):215-22. PubMed ID: 6852866
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin.
    Kievits F, Kijlstra A.
    Immunology; 1985 Mar 01; 54(3):449-56. PubMed ID: 3844370
    [Abstract] [Full Text] [Related]

  • 14. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ, Ramsey J, Hammer CH, Frank MM.
    J Immunol; 1983 Jul 01; 131(1):403-8. PubMed ID: 6602833
    [Abstract] [Full Text] [Related]

  • 15. The modulation of immune complex aggregation by classical pathway-mediated reactions.
    Gronski P, Bodenbender L, Kanzy EJ, Loos M, Seiler FR.
    Immunobiology; 1985 May 01; 169(4):346-61. PubMed ID: 3874147
    [Abstract] [Full Text] [Related]

  • 16. Kinetic studies of phagocytosis. III. The complement-dependent opsonic and anti-opsonic effects of normal and sle sera.
    Håkansson L, Hällgren R, Venge P.
    Immunology; 1982 Sep 01; 47(1):91-9. PubMed ID: 6981589
    [Abstract] [Full Text] [Related]

  • 17. Stabilization of the classical pathway C3 convertase C42, by a factor F-42, isolated from serum of patients with systemic lupus erythematosus.
    Daha MR, Hazevoet HM, Vanes LA, Cats A.
    Immunology; 1980 Jul 01; 40(3):417-24. PubMed ID: 6903557
    [Abstract] [Full Text] [Related]

  • 18. Increased amounts of C4-containing immune complexes and inefficient activation of C3 and the terminal complement pathway in a patient with homozygous C2 deficiency and systemic lupus erythematosus.
    Garred P, Mollnes TE, Thorsteinsson L, Erlendsson K, Steinsson K.
    Scand J Immunol; 1990 Jan 01; 31(1):59-64. PubMed ID: 2300790
    [Abstract] [Full Text] [Related]

  • 19. Stimulation of complement amplification by F(ab')(2)-containing immune complexes and naturally occurring anti-hinge antibodies, possible role in systemic inflammation.
    Lutz HU, Fumia S.
    Autoimmun Rev; 2008 Jun 01; 7(6):508-13. PubMed ID: 18558371
    [Abstract] [Full Text] [Related]

  • 20. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
    Kozlov LV, Shibanova ED, Zinchenko AA.
    Biokhimiia; 1987 Apr 01; 52(4):660-6. PubMed ID: 3647798
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.